Search - tctmd.com

Displaying 61 - 80 of 303

Sort: Relevancy | Date

News Daily News

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Michael O'Riordan

October 24, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies

Todd Neale

October 19, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

Podcast TCTMD Talking Points

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

October 18, 2017

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Todd Neale

October 16, 2017

News Daily News

Merck Calls Quits on CETP Inhibitor Anacetrapib

Michael O'Riordan

October 12, 2017

News Daily News

Blood in Urine Carries Consequences for Patients on Antithrombotics

Yael L. Maxwell

October 09, 2017

Presentation

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

October 09, 2017

News Daily News

NOAC Bleeding Risk Rises With Several Drug Combinations

Michael O'Riordan

October 06, 2017

Presentation CDM 2017

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Presenter: Robert A. Vogel

October 06, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Industry News

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

October 02, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Todd Neale

September 27, 2017

Top Stories in Cardiology, September 2017

Podcast Heart Sounds

Advertisement

More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Merck Calls Quits on CETP Inhibitor Anacetrapib

Blood in Urine Carries Consequences for Patients on Antithrombotics

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

NOAC Bleeding Risk Rises With Several Drug Combinations

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Generic ARBs Linked to Increased Adverse Events

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

TCTMD’s Top 10 Most Popular Stories for September 2017

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

Top Stories in Cardiology, September 2017

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content